Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Silvia Stacchiotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Javier Martín‐Broto(Hospital Universitario Fundación Jiménez Díaz), Nadia Hindi(Hospital Universitario Fundación Jiménez Díaz), Thomas Brodowicz(Vienna General Hospital), Angelo Paolo Dei Tos(University of Padua), Stéphanie Bolle(Institut Gustave Roussy), Hans Gelderblom(Leiden University Medical Center), R. Biagini(Tumori Foundation), Stefan Bielack(Olgahospital), Sebastian Bauer(Science for Life Laboratory), Virginia Ferraresi(Cancer Institute (WIA)), Kateřina Kopečková(University Hospital in Motol), Akira Kawai(NTT (Japan)), Rick L. Haas(Leiden University Medical Center), Mikael Eriksson(Herlev Hospital), Jean‐Yves Blay(Université Claude Bernard Lyon 1), Peter Hohenberger(University of Mannheim), Dagmar Adámková Krákorová(Masaryk Memorial Cancer Institute), Armelle Dufresne(Centre Léon Bérard), Robin L. Jones(Institute of Cancer Research), Giovanni Grignani(Candiolo Cancer Institute), Kjetil Boye(Oslo University Hospital), А. А. Феденко(P.A. Hertzen Moscow Oncology Research Institute), Anna Maria Frezza(University of Milan), Xavier García del Muro(Institut Català d'Oncologia), Sylvie Bonvalot(Dana-Farber Cancer Institute), Angela Buonadonna(Centro di Riferimento Oncologico), Eric Legius(Center for Human Genetics), Aisha Miah(Institute of Cancer Research), Bernadette Brennan(Royal Manchester Children's Hospital), Stefanie Hecker‐Nolting(University College London Hospitals NHS Foundation Trust), Franca Fagioli(Ospedale Regina Margherita), Bernd Kasper(Heidelberg University), I. Boukovinas, Andreas Leithner(Medical University of Graz), Judith V.M.G. Bovée(Leiden University Medical Center), Antonio López–Pousa(Hospital de Sant Pau), F. Gouin(Centre Léon Bérard), Christiane Jungels(Université Libre de Bruxelles), Franel Le Grange(University College London Hospitals NHS Foundation Trust), Axel Le Cesne(Institut Gustave Roussy), Heikki Joensuu(Orion Corporation (Finland)), Jyoti Bajpai(Homi Bhabha National Institute), Andrea Ferrari(University of Milan), A.B. Hassan(University of Oxford), Leo Kager(University of Vienna), Silvia Gasperoni(Azienda Ospedaliero-Universitaria Careggi), Paul C. Jutte(University Medical Center Groningen), N. Abecassis
Cited by 978
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k